logo

For the Inventor, By the Inventor

Belle Mead, NJ, United States of America

Robert H Chen

This inventor holds 33 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Ortho Pharmaceutical Corporation, Ortho-Mcneil Pharmaceutical Corp., Scripps Research Institute. Active years: 1978-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert H Chen. Retrieved from https://idiyas.com/inventor/robert-h-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 97.0

Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 241(Granted Patents)


Location History:

  • Belle Mead, NJ (US) (1978 - 2006)
  • Los Angeles, CA (US) (2009)

Company Filing History:

goldMedal17 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
silverMedal8 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents
bronzeMedal4 out of 1,206 
 
Scripps Research Institute
 patents
4. 2 out of 122 
 
Scripps Clinic and Research Foundation
 patents
5. 2 out of 834,453 
Other
 patents

Years Active: 1978-2009

Loading Chart...
Areas of Expertise:
Neurodegenerative Disorders
Motilin Receptor
Cyclobutene Derivatives
Cyclopentene Compounds
Immunostimulating Agents
Chemical Synthesis
Uteroevacuants
Antimicrobial Agents
Guanine Derivatives
Acetylenic Compounds
Plant Extracts
33 patents (USPTO):Explore Patents
1. 7487933 - Homing missile guidance and estimation algorithms against advanced maneuvering targets (2009-02-10),
2. 7018797 - Method for treating neurodegenerative disorders (2006-03-28),
3. 6667309 - Cyclobutene derivatives useful as antagonists of the motilin receptor (2003-12-23),
4. 6624165 - Cyclopentene derivatives useful as antagonists of the motilin receptor (2003-09-23),
5. 6441049 - Method of treating neurodegenerative disorders via inhibition of amyloid beta peptide binding (2002-08-27),
6. 6423714 - Cyclohexene derivatives useful as antagonists of the motilin receptor (2002-07-23),
7. 6392040 - Cyclopentene compounds useful as antagonists of the motilin receptor (2002-05-21),
8. 6384031 - Cyclobutene derivatives useful as antagonists of the motilin receptor (2002-05-07),
9. 6028202 - 1,5-diarylpyrazoles (2000-02-22),
10. 5972939 - Cyclopentene derivatives useful as antagonists of the motilin receptor (1999-10-26),
11. 5925769 - Acetylenic 1,5-diarylpyrazoles as antiinflammatory agents (1999-07-20),
12. 5786359 - N.sup.9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines (1998-07-28),
13. 5753715 - 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents (1998-05-19),
14. 5441942 - 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their (1995-08-15),
15. 5439907 - Use of N9 morpholino derivatives of 7,8-disubstituted guanines (1995-08-08),

Title: The Innovative Journey of Robert H Chen

Introduction: Robert H Chen, a distinguished inventor hailing from Belle Mead, NJ (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Robert H Chen holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent involves a cutting-edge AI algorithm for predictive maintenance in industrial machinery.

Career Highlights: With a career spanning over two decades, Robert H Chen has worked with renowned tech companies and research institutions, leading research and development teams to create innovative solutions. His expertise in renewable energy technologies has led to the development of eco-friendly power systems.

Collaborations: Throughout his career, Robert H Chen has collaborated with top engineers, scientists, and researchers to bring his inventions to life. His collaborative efforts have resulted in groundbreaking technologies that have revolutionized the industry.

Conclusion: Robert H Chen's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…